Subsequently, it was demonstrated that the expression of CD103/β7 in human colon carcinoma-specific CTLs is synergistically enhanced by the simultaneous stimulation of TGF-β1 and antigen recognition (179). This evidence concerns the gene TGFB1 and colon carcinoma.